HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natalia Cheshenko Selected Research

Nonoxynol (Nonoxynol 9)

1/2011Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.
8/2009Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety.
1/2009Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Natalia Cheshenko Research Topics

Disease

18Infections
11/2022 - 09/2002
4Virus Diseases (Viral Diseases)
02/2016 - 10/2003
4Herpes Genitalis (Genital Herpes)
01/2011 - 09/2006
3Herpes Simplex
03/2015 - 01/2006
1COVID-19
10/2020
1Bites and Stings (Sting)
06/2012
1HIV Infections (HIV Infection)
08/2009
1Inflammation (Inflammations)
01/2009
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
06/2004

Drug/Important Bio-Agent (IBA)

5PRO 2000 (PRO-2000)IBA
01/2011 - 06/2004
5Anti-Infective Agents (Microbicides)IBA
08/2009 - 09/2006
3Acyclovir (Aciclovir)FDA LinkGeneric
01/2013 - 06/2004
3DNA (Deoxyribonucleic Acid)IBA
06/2012 - 12/2005
3Nonoxynol (Nonoxynol 9)FDA Link
01/2011 - 01/2009
2Neutralizing AntibodiesIBA
11/2022 - 10/2020
2InterferonsIBA
02/2016 - 06/2012
2Pharmaceutical PreparationsIBA
01/2013 - 07/2007
2MedroxyprogesteroneIBA
01/2011 - 12/2005
2Tenofovir (Viread)FDA Link
08/2009 - 01/2009
2cellulose sulfateIBA
08/2009 - 06/2004
2Proteins (Proteins, Gene)FDA Link
01/2009 - 09/2002
2Local Anti-Infective Agents (Antiseptics)IBA
07/2007 - 06/2004
2Focal Adhesion Protein-Tyrosine KinasesIBA
12/2006 - 10/2003
2Small Interfering RNA (siRNA)IBA
12/2006 - 09/2005
1VaccinesIBA
11/2022
1AntibodiesIBA
11/2022
1Viral AntigensIBA
11/2022
1Immunoglobulin G (IgG)IBA
11/2022
1CytokinesIBA
10/2020
1Polysaccharides (Glycans)IBA
02/2016
1Antiviral Agents (Antivirals)IBA
02/2016
1ChemokinesIBA
02/2016
1Dynamins (Dynamin)IBA
07/2015
1Viral ProteinsIBA
07/2015
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
07/2015
1Glycoproteins (Glycoprotein)IBA
03/2015
1CalciumIBA
01/2013
1miltefosine (Impavido)IBA
01/2013
1RNA (Ribonucleic Acid)IBA
06/2012
1GelsIBA
01/2011
1BuffersIBA
01/2011
1AdenineFDA LinkGeneric
08/2009
1hydroxyethylcelluloseIBA
01/2009
1Biomarkers (Surrogate Marker)IBA
01/2009
1Reverse Transcriptase InhibitorsIBA
07/2007
1PolymersIBA
01/2007
1Egtazic Acid (EGTA)IBA
12/2006
1NectinsIBA
12/2006
1Proline (L-Proline)FDA Link
09/2005
1Tyrosine (L-Tyrosine)FDA Link
09/2005
1polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric
06/2004
1Etoposide (VP 16)FDA LinkGeneric
05/2004
1theta-defensinIBA
05/2004
1alpha-DefensinsIBA
02/2003
1Immediate-Early ProteinsIBA
09/2002

Therapy/Procedure

1Therapeutics
01/2007